Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Neumora Therapeutics, Inc. | Director | Common Stock | 20.1K | $241K | $11.98 | Jun 13, 2024 | Direct |
Neumora Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 28.6K | Jun 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NMRA | Neumora Therapeutics, Inc. | Jun 13, 2024 | 2 | $0 | 4 | Jun 14, 2024 | Director |
NMRA | Neumora Therapeutics, Inc. | Sep 14, 2023 | 1 | $0 | 4 | Sep 18, 2023 | Director |
NMRA | Neumora Therapeutics, Inc. | Sep 14, 2023 | 0 | $0 | 3 | Sep 14, 2023 | Director |